Lucy Mangan: These drugs are a disaster for society

As they slim down, UK and US users of GLP-1 jabs and pills are changing their spending habits – and their wardrobes

Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk's obesity injection Wegovy and diabetes counterpart Ozempic.